National Health Investors, Inc.
NHI
$75.02
-$0.05-0.07%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 263.73M | 257.05M | 251.99M | 250.92M | 246.12M |
| Total Other Revenue | 79.89M | 78.54M | 77.86M | 76.09M | 73.57M |
| Total Revenue | 343.62M | 335.58M | 329.85M | 327.01M | 319.68M |
| Cost of Revenue | 1.81M | 1.15M | 3.05M | 2.47M | 2.56M |
| Gross Profit | 341.80M | 334.44M | 326.80M | 324.54M | 317.12M |
| SG&A Expenses | 24.17M | 21.79M | 21.03M | 20.48M | 19.92M |
| Depreciation & Amortization | 73.10M | 71.44M | 69.87M | 69.62M | 69.86M |
| Other Operating Expenses | 53.18M | 52.73M | 49.97M | 49.89M | 49.35M |
| Total Operating Expenses | 152.26M | 147.11M | 143.92M | 142.46M | 141.69M |
| Operating Income | 191.36M | 188.48M | 185.93M | 184.55M | 177.99M |
| Income Before Tax | 139.80M | 136.64M | 125.57M | 126.36M | 130.84M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 139.80 | 136.64 | 125.57 | 126.36 | 130.84 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | 20.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.41M | 1.35M | 1.22M | 1.23M | 1.26M |
| Net Income | 141.20M | 137.99M | 126.79M | 127.60M | 132.12M |
| EBIT | 191.36M | 188.48M | 185.93M | 184.55M | 177.99M |
| EBITDA | 264.45M | 259.92M | 255.80M | 254.17M | 247.85M |
| EPS Basic | 3.17 | 3.14 | 2.92 | 2.94 | 3.04 |
| Normalized Basic EPS | 1.89 | 1.86 | 1.85 | 1.83 | 1.75 |
| EPS Diluted | 3.15 | 3.12 | 2.91 | 2.93 | 3.04 |
| Normalized Diluted EPS | 1.87 | 1.85 | 1.84 | 1.83 | 1.75 |
| Average Basic Shares Outstanding | 177.71M | 175.38M | 173.65M | 173.56M | 173.56M |
| Average Diluted Shares Outstanding | 178.86M | 176.41M | 174.36M | 173.77M | 173.59M |
| Dividend Per Share | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 |
| Payout Ratio | 112.29% | 113.43% | 123.29% | 122.49% | 118.27% |